5-((2,4-DIOXO-5-THIAZOLIDINYL)METHYL)-2-METHOXY-N-((4-(TRIFLUOROMETHYL)PHENYL)METHYL)BENZAMIDE
UNII 2CP9XG3TH2
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-n-((4-(trifluoromethyl)phenyl)methyl)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2CP9XG3TH2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 213252-19-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H17F3N2O4S NFFXEUUOMTXWCX-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-n-((4-(trifluoromethyl)phenyl)methyl)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.